Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-18-011456
Filing Date
2018-04-16
Accepted
2018-04-16 13:23:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 36439
  Complete submission text file 0000000000-18-011456.txt   50808
Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Filed for) CIK: 0001645666 (see all company filings)

EIN.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations